翰思艾泰-B(03378)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03378 翰思艾泰-B

未开盘 07-02 15:58:13

28.400

-0.200

-0.70%

最高29.460	最低27.900	成交量4.27万
今开28.600	昨收28.600	日振幅5.45%
总市值38.34亿	流通市值38.34亿	总股本1.35亿
成交额122.33万	换手率0.03%	流通股本1.35亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03378","market":"HK","secType":"STK","nameCN":"翰思艾泰-B","latestPrice":28.4,"timestamp":1782979093461,"preClose":28.6,"halted":0,"volume":42700,"delay":0,"changeRate":-0.006993006993007092,"floatShares":135000000,"shares":135000000,"eps":-1.11,"marketStatus":"未开盘","change":-0.2,"latestTime":"07-02 15:58:13","open":28.6,"high":29.46,"low":27.9,"amount":1223310,"amplitude":0.054545,"askPrice":28.78,"askSize":600,"bidPrice":28.48,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.077,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783042200000},"marketStatusCode":0,"adr":0,"listingDate":1766419200000,"exchange":"SEHK","adjPreClose":28.6,"openAndCloseTimeList":[[1782955800000,1782964800000],[1782968400000,1782979200000]],"volumeRatio":0.2509697893785367,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000905","market":"SZ","secType":"STK","nameCN":"厦门港务","latestPrice":8.09,"timestamp":1782975600000,"preClose":8.01,"halted":0,"volume":13876000,"delay":0,"premium":"+203.81"}},"requestUrl":"/m/hq/s/03378","defaultTab":"news","newsList":[{"id":"2648714686","title":"翰思艾泰-B(03378.HK)与TwinEdge Bioscience 开展AI药物研发合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2648714686","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648714686?lang=zh_cn&edition=full","pubTime":"2026-07-02 23:02","pubTimestamp":1783004573,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1535","03378","BK1173","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169455649","title":"翰思艾泰-B回购16,000股股份，耗资约45.60万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169455649","media":"公告速递","labels":[],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169455649?lang=zh_cn&edition=full","pubTime":"2026-07-02 19:55","pubTimestamp":1782993319,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司于2026年7月2日发布翌日披露报表，公告于香港联交所场内回购股份，涉及16,000股普通股（H股），占本次变动前公司已发行股本约0.012%。本次回购的最高价为每股28.68港元，最低价为每股27.96港元，平均购回价约为每股28.5004港元，合计支付对价约45.60万港元。截至本公告发布，翰思艾泰-B已累计回购189,600股，占授权通过当日已发行股份总数的约0.1408%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B回购16,000股股份，耗资约45.60万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648504620","title":"翰思艾泰-B(03378)7月2日斥资45.6万港元回购1.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648504620","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648504620?lang=zh_cn&edition=full","pubTime":"2026-07-02 19:22","pubTimestamp":1782991363,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B(03378)发布公告，于2026年7月2日斥资45.6万港元回购1.6万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03378","BK1173","BK1535","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647155687","title":"翰思艾泰-B(03378)6月30日斥资195.02万港元回购6.96万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647155687","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647155687?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:35","pubTimestamp":1782822904,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B(03378)发布公告，于2026年6月30日斥资195.02万港元回购6.96万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461448.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","03378","BK1173","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136900983","title":"翰思艾泰-B回购69,600股股份，涉资约195.02万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1136900983","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136900983?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:32","pubTimestamp":1782822744,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司于2026年6月30日披露翌日披露报表，宣布在香港联交所场内回购股份。每股回购价在每股27.00港元至28.30港元之间，总成交金额1,950,184港元，折合约195.02万港元。回购完成后，公司已发行股份数为134,523,230股，库藏股为1,695,600股，合计136,218,830股。根据公告，购回授权的决议于2026年6月24日获通过，公司可购回股份总数为13,469,683股。截至公告日，根据该授权已回购173,600股，占授权通过当日已发行股份总数的约0.1289%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"翰思艾泰-B回购69,600股股份，涉资约195.02万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168711207","title":"翰思艾泰-B获选2026中国医药创新种子企业100强","url":"https://stock-news.laohu8.com/highlight/detail?id=1168711207","media":"翰思艾泰投资者...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168711207?lang=zh_cn&edition=full","pubTime":"2026-06-30 16:18","pubTimestamp":1782807481,"startTime":"0","endTime":"0","summary":"国内医药行业权威媒体《E药经理人》近期发布2026“中国医药创新种子企业100强”榜单。图片“中国医药创新种子企业100强”是成熟榜单“中国医药创新企业100强”的衍生榜单，主要面向研发取得阶段性进展、处于成长阶段的创新药企。未来，翰思艾泰将继续以科学之力攻克疾病难关，为全球患者提供更有效、更安全的创新治疗方案。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://mp.weixin.qq.com/s/5STMgGERKtcmRIPQ-BmR1A","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1782807499093","symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647560375","title":"翰思艾泰-B(03378)6月29日斥资102.33万港元回购3.72万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647560375","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647560375?lang=zh_cn&edition=full","pubTime":"2026-06-29 18:56","pubTimestamp":1782730596,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B(03378)发布公告，于2026年6月29日斥资102.33万港元回购3.72万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460488.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1535","BK1173","BK1161","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119317127","title":"翰思艾泰-B 6月29日回购3.72万股，耗资约102.33万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119317127","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119317127?lang=zh_cn&edition=full","pubTime":"2026-06-29 18:56","pubTimestamp":1782730580,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司于2026年6月29日进行股份回购，涉及数量37,200股，约占该事件前已发行股本的0.028%。本次回购的每股价格介乎26.30港元至27.92港元，合共付出约102.33万港元。回购完成后，公司已发行股本为134,592,830股，库藏股数量增至1,626,000股，总股本维持136,218,830股。回购完成后，后续任何新的股份发行或库藏股再次出售、转让需遵守暂止期安排，暂止期至2026年7月29日止。公司确认已符合法定程序及香港联交所相关上市规则的要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B 6月29日回购3.72万股，耗资约102.33万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646351643","title":"翰思艾泰-B(03378)6月26日斥资113.51万港元回购4.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646351643","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646351643?lang=zh_cn&edition=full","pubTime":"2026-06-26 19:06","pubTimestamp":1782472007,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B(03378)发布公告，于2026年6月26日斥资113.51万港元回购4.4万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1535","03378","BK1173","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112983774","title":"翰思艾泰-B：6月26日回购4.4万股股份，涉资约113.51万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112983774","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112983774?lang=zh_cn&edition=full","pubTime":"2026-06-26 19:06","pubTimestamp":1782471975,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司于2026年6月26日发布翌日披露报表，公告当日通过香港联交所场内回购4.4万股H股。每股回购价格介乎24.96港元至28港元，总金额约113.51万港元。回购完成后，公司已发行股本总数为136,218,830股，其中134,630,030股为已发行股份，1,588,800股为库存股。公司表示，回购授权于2026年6月24日获股东大会批准，可回购总数为13,469,683股。公告同时确认，上述回购行为已遵守香港联合交易所有限公司证券上市规则及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"翰思艾泰-B：6月26日回购4.4万股股份，涉资约113.51万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199404452","title":"翰思艾泰-B回购2.28万股，耗资约62.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1199404452","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199404452?lang=zh_cn&edition=full","pubTime":"2026-06-24 21:56","pubTimestamp":1782309409,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司于2026年6月24日发布翌日披露报表，宣布在香港联合交易所回购普通股H股2.28万股，占回购前已发行股份的约0.017%。本次回购价格介于每股26.9港元至28.1港元之间，合计支付629,906港元。公告显示，本次回购完成后，公司已发行股份数量由6月23日的134,696,830股降至134,674,030股；库藏股数量增至1,544,800股；公司股本总数保持在136,218,830股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B回购2.28万股，耗资约62.99万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645816191","title":"翰思艾泰-B(03378.HK)6月24日斥资约62.99万港元回购2.28万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645816191","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645816191?lang=zh_cn&edition=full","pubTime":"2026-06-24 21:55","pubTimestamp":1782309354,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1535","BK1173","03378","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645004815","title":"翰思艾泰-B(03378)：控股股东承诺自愿延长禁售期","url":"https://stock-news.laohu8.com/highlight/detail?id=2645004815","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645004815?lang=zh_cn&edition=full","pubTime":"2026-06-24 21:28","pubTimestamp":1782307739,"startTime":"0","endTime":"0","summary":"近日，公司接获全体控股股东的通知，据此，控股股东承诺自原禁售期届满日期至其后的12个月的延长禁售期期间，不会以任何方式减持彼等各自持有的公司股份。公司认为，禁售期延长表明前述股东对公司的未来前景、核心技术实力及长期价值充满信心。前述股东亦将持续审阅公司业绩，且或将基于公司的业务发展情况考虑进一步延长禁售期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1458358.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1535","BK1173","BK1161","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645864073","title":"港股异动 | 翰思艾泰-B(03378)午后涨近7% 获纳入富时全球股票微盘股指数 公司重磅品种亮相AACR年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2645864073","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645864073?lang=zh_cn&edition=full","pubTime":"2026-06-24 13:56","pubTimestamp":1782280580,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，翰思艾泰-B午后涨近7%，截至发稿，涨6.99%，报28.48港元，成交额955.72万港元。消息面上，近日，翰思艾泰-B发布公告，根据富时罗素关于富时全球股票指数系列的季度检讨结果，翰思艾泰已被纳入富时全球股票微盘股指数。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1173","BK1161","VXUS","03378","BK1535","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181403253","title":"港股直击 | 翰思艾泰-B升7%，获纳入富时全球微盘股指数，创新管线亮相AACR年会","url":"https://stock-news.laohu8.com/highlight/detail?id=1181403253","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181403253?lang=zh_cn&edition=full","pubTime":"2026-06-24 13:48","pubTimestamp":1782280122,"startTime":"0","endTime":"0","summary":"翰思艾泰-B午后涨近7%，截至发稿，升6.99%，报28.48港元，成交额955.72万港元。近日，翰思艾泰-B发布公告，根据富时罗素关于富时全球股票指数系列的季度检讨结果，翰思艾泰已被纳入富时全球股票微盘股指数。此前，翰思艾泰-B在2026年美国癌症研究协会年会上，以壁报形式重磅发布CTLA-4/SIRPα双功能融合蛋白HX044、双特异性抗体药物偶联物HX116、PD-L1靶向ADC HX112以及3D肿瘤类器官ADC评价体系等四项核心临床前研究成果，进一步验证公司的研发实力与创新能力。","market":"hk","thumbnail":"https://static.tigerbbs.com/765160633e02a57826badc309853c153","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/765160633e02a57826badc309853c153"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195378372","title":"翰思艾泰-B回购144,100股股份，耗资约381.52万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195378372","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195378372?lang=zh_cn&edition=full","pubTime":"2026-06-23 18:16","pubTimestamp":1782209761,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司于2026年6月23日公告，宣布于香港联交所场内回购144,100股H股股份，占该次回购前公司已发行股份总数约0.107%。根据公告，回购价格介乎每股25.88港元至27.48港元，合计支付约3,815,188港元，折合约381.52万港元。公告显示，此次回购完成后，公司已发行股份数量由原先的约134,840,930股减少至约134,696,830股，同时库藏股数量增至1,522,000股，已发行股本总数维持136,218,830股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B回购144,100股股份，耗资约381.52万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120891905","title":"翰思艾泰-B：6月22日回购2.24万股股份，涉资约59.68万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120891905","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120891905?lang=zh_cn&edition=full","pubTime":"2026-06-22 19:56","pubTimestamp":1782129404,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司于2026年6月22日发布公告，披露当日在香港联交所场内回购股份的情况。公告显示，公司于当日回购普通股H股22,400股，占公司现有已发行股本约0.017%，每股回购价格介乎每股26.18港元至27.08港元，总支付金额为596,756港元，折合约59.68万港元。本次回购股份将持作公司库藏股。公司于2026年2月12日通过购回授权，可回购股份总数为13,621,883股。公司同时确认在本次回购过程中，已遵守香港联交所证券上市规则及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B：6月22日回购2.24万股股份，涉资约59.68万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645024369","title":"翰思艾泰-B(03378)6月22日斥资59.7万港元回购2.24万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645024369","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645024369?lang=zh_cn&edition=full","pubTime":"2026-06-22 19:55","pubTimestamp":1782129302,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B(03378)发布公告，于2026年6月22日斥资59.7万港元回购2.24万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457109.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03378","BK1173","BK1161","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645823045","title":"翰思艾泰-B(03378)获纳入富时全球股票微盘股指数","url":"https://stock-news.laohu8.com/highlight/detail?id=2645823045","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645823045?lang=zh_cn&edition=full","pubTime":"2026-06-22 12:46","pubTimestamp":1782103587,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B 发布公告，根据富时罗素关于富时全球股票指数系列的季度检讨结果，翰思艾泰已被纳入富时全球股票微盘股指数。富时全球股票指数系列提供稳健的全球股票指数框架，该系列横跨全球49个发达和新兴市场，涵盖19,000多只大、中、小盘和微盘股票，是全球广泛认可的基准指数之一。董事会认为，此次公司获纳入富时全球股票微盘股指数，反映了国际资本市场对公司稳健基本面、创新能力及增长潜力的广泛认可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456785.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B(03378)获纳入富时全球股票微盘股指数","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1173","03378","BK1161","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147848245","title":"翰思艾泰-B将于2026年6月19日起纳入富时全球微型股指数","url":"https://stock-news.laohu8.com/highlight/detail?id=1147848245","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147848245?lang=zh_cn&edition=full","pubTime":"2026-06-22 12:19","pubTimestamp":1782101955,"startTime":"0","endTime":"0","summary":"翰思艾泰-B（Wuhan）股份有限公司宣布，公司股票将于2026年6月19日起正式被纳入富时全球微型股指数（FTSE Global Micro Cap Index）。\n此次入选标志着公司在资本市场的表现与规模获得了国际主流指数的认可。纳入该指数有望提升公司在全球投资者中的知名度，并可能吸引更多追踪该指数的被动资金流入。\n富时全球微型股指数由富时罗素（FTSE Russell）编制，旨在涵盖全球范围内符合特定市值标准的小型上市公司，为投资者提供重要的投资参考基准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378","BK1173","BK1161","BK1535"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hanxbio.com/","stockEarnings":[{"period":"1week","weight":0.0457},{"period":"1month","weight":0.0661},{"period":"3month","weight":-0.1158},{"period":"6month","weight":0.6647},{"period":"1year","weight":-0.1125},{"period":"ytd","weight":0.7772}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":-0.1146},{"period":"3month","weight":-0.0821},{"period":"6month","weight":-0.1247},{"period":"1year","weight":-0.0482},{"period":"ytd","weight":-0.1005}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"翰思艾泰生物医药科技（武汉）股份有限公司是一家主要从事肿瘤免疫疗法的研发的中国公司。该公司的产品管线有针对肿瘤学的临床阶段候选药物和临床前阶段候选药物，包括核心产品HX009及主要产品HX301及HX044，以及针对自身免疫和肿瘤市场的抗体偶联药物、双特异性抗体及单克隆抗体。HX009是一种自主研发的抗程序性细胞死亡蛋白1（PD-1）/信号调节蛋白α（SIRPα）双功能抗体融合蛋白。HX301是一种靶向集落刺激因子-1受体（CSF1R）、AMPK相关蛋白激酶5（ARK5）、FMS样酪氨酸激酶3（FLT-3）及细胞周期蛋白依赖性激酶4/6（CDK4/6）等关键通路的多靶点激酶抑制剂。HX044为一种新型双重功能抗细胞毒性T淋巴细胞相关蛋白4（CTLA-4）抗体SIRPα融合蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.005427},{"month":2,"riseRate":0.411765,"avgChangeRate":0.008835},{"month":3,"riseRate":0.352941,"avgChangeRate":-0.021319},{"month":4,"riseRate":0.705882,"avgChangeRate":0.100651},{"month":5,"riseRate":0.352941,"avgChangeRate":0.046508},{"month":6,"riseRate":0.470588,"avgChangeRate":-0.00883},{"month":7,"riseRate":0.470588,"avgChangeRate":0.004276},{"month":8,"riseRate":0.470588,"avgChangeRate":-0.031033},{"month":9,"riseRate":0.588235,"avgChangeRate":-0.013577},{"month":10,"riseRate":0.75,"avgChangeRate":0.019136},{"month":11,"riseRate":0.625,"avgChangeRate":0.009468},{"month":12,"riseRate":0.625,"avgChangeRate":0.056179}],"exchange":"SEHK","name":"翰思艾泰-B","nameEN":"HANXBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翰思艾泰-B(03378)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翰思艾泰-B(03378)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翰思艾泰-B,03378,翰思艾泰-B股票,翰思艾泰-B股票老虎,翰思艾泰-B股票老虎国际,翰思艾泰-B行情,翰思艾泰-B股票行情,翰思艾泰-B股价,翰思艾泰-B股市,翰思艾泰-B股票价格,翰思艾泰-B股票交易,翰思艾泰-B股票购买,翰思艾泰-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翰思艾泰-B(03378)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翰思艾泰-B(03378)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}